Clinton E. Leysath

CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells

Linhua Jin, Yoko Tabe, Sergej Konoplev et al. · Molecular Cancer Therapeutics · 2008 · 204 citations · Full text

Medicine, Hematology, Oncology +15

Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia

Marina Konopleva, Twee Tsao, Peter P. Ruvolo et al. · Blood · 2002 · 189 citations · Full text

Medicine, Oncology, Pharmacology +13

The sub‐nanomolar binding of DNA–RNA hybrids by the single‐chain Fv fragment of antibody S9.6

Damilola D. Phillips, David N. Garboczi, Kavita Singh et al. · Journal of Molecular Recognition · 2013 · 160 citations · Full text

Pharmacy, Biotechnology, Molecular Biology +13

Synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia

Michèle Milella, Zeev Estrov, Steven M. Kornblau et al. · Blood · 2002 · 119 citations · Full text

Life Sciences, Cell Biology, Oncology +12

A Single VHH-Based Toxin-Neutralizing Agent and an Effector Antibody Protect Mice against Challenge with Shiga Toxins 1 and 2

Jacqueline M. Tremblay, Jean Mukherjee, Clinton E. Leysath et al. · Infection and Immunity · 2013 · 105 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17